We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.7M
1-Year Est. Return 43.1%
This Fund
S&P 500
This Quarter Est. Return
-49.81%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
AUM
$95.4M
AUM Growth
Cap. Flow
+$165M
Cap. Flow %
173.28%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AQST icon
Aquestive Therapeutics
AQST
+$145M
2
DNLI icon
Denali Therapeutics
DNLI
+$20.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$452M
$72.5M 75.94%
+11,503,294
New +$145M
DNLI icon
2
Denali Therapeutics
DNLI
$3.79B
$23M 24.06%
+1,111,799
New +$20.2M

Similar funds

Bratton Capital Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Bratton Capital Management, which disclosed 2 positions worth $95.4M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Aquestive Therapeutics: 11,503,294 shares worth $72.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Bratton Capital Management's largest Q4 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $72.5M.
  • Bratton Capital Management's ten largest holdings make up 100% of its $95.4M portfolio in Q4 2018.
  • Bratton Capital Management disclosed 2 positions in Q4 2018, its first 13F filing on record.

Based on Bratton Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.